Brevetti EPO No.3595657 2026.08.26
Brevetti EPO
(10) Registration Number and Date
2026000412 2026.10.02
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000412 2018.03.13
(40) Publication Number and Date
SM /T/2026/000412 2026.10.02
(30) Priority Details
WO PCT/EP2017/055994
2017.03.14
(51) IPC Classes
(72) Inventor
(IT) POUZOL, Laetitia : c/o Idorsia Pharmaceuticals Ltd.Hegenheimermattweg 91, 4123 Allschwil, CH
(74) Representative Name
(IT) NAPOLEONE, Maria Pace : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) COMBINAZIONE FARMACEUTICA COMPRENDENTE PONESIMOD E TERIFLUNOMIDE O LEFLUNOMIDE E SUO UTILIZZO NEL TRATTAMENTO DELLA SCLEROSI MULTIPLA
(EN) PHARMACEUTICAL COMBINATION COMPRISING PONESIMOD AND TERIFLUNOMIDE OR LEFLUNOMIDE AND ITS USE IN THE TREATMENT OF MULTIPLE SCLEROSIS
(57) Abstract
(58) Citations
Document Type Date Action
Event NameDateStatus
Filing2018.03.13Filed
Brevetto EPO concesso2026.10.02Registered